Pixium Sees Way Forward For Its Vision-Restoring Implants In A Tough Market

 
• By Barnaby Pickering

The company has just two quarters’ of cash remaining, but has also achieved major milestones towards the development and commercialization of its implant that hopes to restore vision in patients with age-related macular degeneration.  

The way forward for patients with macular degeneration may be clearer once Prima comes to market • Source: Shutterstock

More from Policy & Regulation

More from Medtech Insight